Coronavirus vaccine researcher: 'People will die because of a lack of faith in the system'

The clearest way for the U.S. to emerge from the coronavirus pandemic, Stat News reports, is to achieve herd immunity through vaccination. Experts estimate that will occur once 50 to 70 percent of the population is protected. But, as Kawsar Talaat, a vaccine researcher at Johns Hopkins University points out, "the most effective vaccine in the world is useless if no one will accept it."
There's a lot of skepticism about a coronavirus vaccine across the political spectrum in the U.S. A new Axios poll released Tuesday showed that only 43 percent of Democrats and 33 percent of Republicans would take a first-generation vaccine as soon as it's available, and the numbers have trended downward rapidly over the last few months.
The expectation is that there will be more than one vaccine rolling out over time, so it's possible those numbers would go back up as safety and efficacy become more clear, but there's certainly a disconnect between the public and the government and scientific community on the issue. "I think people will die because of a lack of faith in the system," Talaat said, arguing that the Centers for Disease Control and Prevention have wavered on testing guidelines, and the Food and Drug Administration has been undermined by the optics of political interference from the Trump Administration. Stat notes that others want vaccine makers to be more transparent about the process.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Either way, Talaat said, "you can't talk your way into trust. You need to demonstrate that you're trustworthy, and that the process is trustworthy." Read more about how the pandemic may play out over the course of the next year at Stat News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
'Extremists still find plenty of digital spaces'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
South Carolina to execute prisoner by firing squad
speed read Death row inmate Brad Sigmon prefers the squad over the electric chair or lethal injection, his lawyer said
By Peter Weber, The Week US Published
-
Trump eases Mexico, Canada tariffs again as markets slide
speed read The president suspended some of the 25% tariffs he imposed on Mexican and Canadian imports
By Rafi Schwartz, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published